We isolated a partial cDNA encoding a novel chicken homologue of human Deltex (DTX1), a member of the Notch signaling pathway. The cDtx2 sequence showed higher homology to KIAA0937 protein (92% identical) than to DTX1 (68% identical). cDtx2 is expressed widely in the epiblast at stage 4. Later in development it is expressed in many neural and sensory structures, such as neural tube, migrating neural crest cells, epidermal placodes, cranial ganglia, and the optic and otic vesicles. q
Results and discussion
Notch-mediated signaling plays an important role during development of¯ies, nematodes and vertebrates. Studies in Drosophila identi®ed several genes involved in the Notch pathway including Delta, Serrate, Suppressor of Hairless (Su(H)), Enhancer of split (E(spl)) and Deltex (Weinmaster, 1997; Egan et al., 1998) . Vertebrate homologues for most of these genes have been identi®ed (Robey, 1997; Lendahl, 1998) . Deltex is the least understood member of the Notch pathway. Drosophila Deltex interacts with Notch (Xu and Artavanis-Tsakonas, 1990 ) by binding to Notch ankyrin repeats . However, the function of Deltex is still unknown and Deltex was not included in recent models of Notch-mediated signaling (Kopan and Turner, 1996; Bray, 1998) . In situ hybridization and immunocytochemistry in Drosophila revealed ubiquitous expression of Deltex (Busseau et al., 1994) . Matsuno and coworkers also concluded that a human homologue of Deltex, DTX1, was expressed ubiquitously based on northern blot analysis (Matsuno et al., 1998) . However, using in situ hybridization these authors found non-uniform distribution of DTX1 mRNA in several embryonic human tissues. (Matsuno et al., 1998) .
A clone containing partial sequence of a chicken homologue of Deltex, cDtx2, was selected in a one-hybrid screen using a cDNA library prepared from the ciliary epithelium of E7 chicken embryos. The functional signi®cance of cDtx2 interaction with the`bait' used in this screen is being evaluated and will be described elsewhere. The cloned fragment was 1218 bp in length and encoded a protein that was 68% identical to the C-terminus of human DTX1 and mouse FX-1 proteins and 92% identical to KIAA0937 (DTX2) protein from the HUGE project (Nagase et al., 1999) (Fig. 1) . The fragment includes the RING-H2 zinc ®nger domain and C-terminal domain, the regions most conserved between all members of the Deltex family (Matsuno et al., 1998) . These results suggested that we identi®ed a new vertebrate homolog of the Deltex gene and that cDtx2 and KIAA0937 (DTX2) are orthologs.
We analyzed the expression of chicken cDtx2 mRNA by whole-mount in situ hybridization from stage 4 to stage 25 (E4) (Hamburger and Hamilton, 1951) . The expression pattern of cDtx2 was highly tissue and region speci®c and overlapped with the known expression pattern of Notch family members (Williams et al., 1995; Lindsell et al., 1996; Myat et al., 1996) . At stage 4 cDtx2 was expressed throughout the embryonic and extraembryonic epiblast, except for Hensen's node and the primitive streak (Fig.  3A±D ). As the embryo developed cDtx2 continued to be expressed in the neural plate, ectoderm, extraembryonic ectoderm and neural tube (Figs. 2A and 3E±L).
Expression in the spinal cord and the brain
Expression of cDtx2 was uniformly distributed in the prospective spinal cord at earlier stages from stage 8 to 15 (Figs. 2 and 3G, H, L, N) . At later stages 22±25 expression of cDtx2 became restricted to the ventricular zone, which contains proliferating precursor cells (Fig. 3Q,U) . At all stages there was minimal expression in the¯oor plate. At stages 9, 10 and 12 cDtx2 expression was seen in the neural and surface ectoderm. As development proceeded, cDtx2 expression became stronger in the closed neural tube and weaker in the ectoderm (Figs. 2A±C and 3L) . At stages 9 and 10 cDtx2 was expressed throughout the brain with higher expression in the forebrain and midbrain (Figs. 2A and 3E±F, J±K) . From stage 12 to 15 cDtx2 mRNA levels increased in the optic vesicle and hindbrain (Fig. 2B ,C and data not shown). From stage 15 to 24 signal in the diencephalon and telencephalon decreased (Fig. 2D ,F±H, and data not shown). At the same time, signal in the mesencephalon, myelencephalon and metencephalon increased and became restricted to the ventricular zone (Fig. 3S,T) as in spinal cord. Staining for cDtx2 was not detected in the¯oor plate and roof plate. In the spinal cord and brain the area Fig. 1 . The predicted protein sequence of cDt2x (GenBank number AF184236) was aligned with that of human DTX1 (GenBank number AF053700) and KIAA0937 (GenBank number AB023154). Green shaded residues are identical in all three proteins. Blue shaded residues are identical between KIAA0937 (DTX2) and cDtx2 proteins. Pink shaded residues are identical between DTX1 and cDtx2 proteins. Yellow shaded residues are identical between DTX1 and KIAA0937 (DTX2) proteins. Asterisks denote the cysteine and histidine residues characteristic of RING-H2 zinc ®ngers. of the expression of cDtx2 was broader in dorsal part and narrowed in more ventral regions, as seen on Fig. 3S ,T.
Expression in the eye
At stage 12 cDtx2 expression was seen in the outer half of the optic vesicle and the thickened lens placode (Fig. 3M) . As the optic cup formed at stage 15 cDtx2 expression increased and was present in the prospective neural retina, invaginating lens placode, and optic stalk (Fig. 3O) . At this stage signal was not detected in the prospective retinal pigmented epithelium. At stages 22 and 25 cDtx2 expression disappeared from the lens but continued to be expressed in the neural retina (Fig. 3V ).
Expression in neural crest cells and epidermal placodes
cDtx2 was detected in migrating cranial and trunk neural Abbreviations: (cn) cranial nerves, (cpc) circumpharyngeal neural crest cells which will form the cranial nerve complexes IX, X and XI, (di) diencephalon, (drg) dorsal root ganglion, (fb) forebrain, (gX) cranial ganglion X, (hb) hindbrain, (hyc) hyoid neural crest cells which will form the cranial nerve complexes VII and VIII, (mb) midbrain, (mes) mesencephalon, (met) metencephalon, (ncc) neural crest cells, (np) nasal placode, (nt) neural tube, (ops) optic stalk, (opv) optic vesicle, (otv) otic vesicle, (s) somite, (te) telencephalon, (trgc) trigeminal neural crest cells which will form the cranial nerve complexes V. crest cells. Stripes of cDtx2-positive cells, apparently migrating toward the branchial arches and cranial ganglia, were seen at all stages examined (Figs. 2 and 3J ). cDtx2 was also expressed in the epibranchial placodes, the placodal epithelial cells that contribute to the cranial ganglia, and in migrating presumptive neuroblasts derived from those placodes (data not shown). At later stages cDt2x transcripts were detected in the cranial ganglia and cranial nerves (Fig.  3N ,R,T and data not shown). Migrating trunk neural crest and dorsal root ganglion cells also expressed cDtx2 mRNA (Fig. 3Q,U) .
Strong expression of cDtx2 was seen in the otic placode and the developing vesicle (Figs. 2B,C,E and 3K). cDtx2 was detected in the nasal placodes as they began to invaginate (data not shown). Transient expression of cDtx2 was also seen in the somites soon after they formed (Figs. 2A±C  and 3L ). Expression of cDtx2 was observed in developing kidney at stages 22 and 25 (Fig. 3Q,U) , in the liver (Fig. 3P ) and around the dorsal aorta (Fig. 3U ).
Methods.

A plasmid containing the 3
H region of cDt2x cDNA was obtained from a cDNA library prepared from E7 chicken embryo ciliary epithelium poly(A) 1 RNA. The cDNA insert was transformed into pGEM3Zf(1), sequenced and submitted to GenBank under accession number AF184236. The deduced protein sequence was aligned with human and mouse homologues using CLUSTAW program on the Washington University web server.
Sense and antisense probes were prepared using digoxigenin-11-rUTP (Roche Molecular Biochemical) and T7 RNA polymerase (Ambion). Whole-mount in situ hybridization was carried out as described (Nieto et al., 1996) with minor modi®cations using an alkaline phosphatase-coupled anti-digoxigenin antibody and NBT and BCIP (Roche Molecular Biochemical). All vesicles in the brain and the eye were punched or cut open to insure good penetration of the probe and the antibody. For embryos at stages 4±9 proteinase K treatment was omitted. Stained embryos were photographed, embedded in 2.5% acrylamide, 3% low melting agarose in PBS and sectioned at 100 mm in a tissue slicer (EM Sciences) (Germroth et al., 1995) . For embryos at stages 22 and 25 in situ hybridization was also performed on 100 mm sections.
